Dr. Rabindera Nath Mehrotra

Dr. Rabindera Nath Mehrotra is an Endocrinologist based in Hyderabad, currently attached to Apollo Hospital in Jubilee Hills. Dr. Mehrotra has an MBBS and an MD in Medicine from MLN Medical College, Allahabad. In addition, he has completed the postdoctoral DM superspecialisation in Endocrinology from SGPGIMS Lucknow and also obtained the DNB (Diplomate of the National Board) title in Endocrinology from the National Board of Examinations, New Delhi. Dr. Mehrotra is a certified Clinical... [+]

Testimonials

Appointment Information

+

Apollo Hospitals (Department of Endocrinology)

Mon

By Appointment

Tue

By Appointment

Wed

By Appointment

Thu

By Appointment

Fri

By Appointment

Sat

By Appointment

Sun

Jubilee Hills, Hyderabad - 500033

Tel: (040) 23542734 / (040) 23607777 Extn. 3035

URL: Visit website

View on Google Maps

Research

Principal Investigator: PEARL TRIAL. A multi-centric, randomised, double-blind, 3+2 year trial in osteoporosis. Published - Title: Lasafoxifene in postmenopausal women with osteoporosis.

NEJM. 2010; Volume 362; pp. 686-696.

Principal Investigator: GENERATIONS TRIAL. A multi-centric, randomised, double blind, 5-year trial in osteoporosis.

Principal Investigator: A multi-centric Phase 2B long-term, randomised, open-label safety and tolerability trial comparing with routine care in patients with chronic painful diabetic peripheral neuropathy.

[+]

Principal Investigator: A multi-centric, randomised trial on osteoporosis Phase 3, open-label trial for parathyroid hormone. A randomised control open-labeled study in India. [Published]

Principal Investigator: A multi-centric Phase 3 trial randomised, double-blind comparison of two different statins in patients with Type II diabetes mellitus.

Principal Investigator: A multi-centric Phase 4 trial randomised – for type II Diabetes Mellitus. The durability of twice daily insulin lispro low mixture compared to once-daily Glargine in patients with Type-2 diabetes and inadequate glycemic control. [Published]

Principal Investigator: A multi-centric Phase 3 trial, randomised, double-blind - Comparing the efficacy and safety of a fixed combination of Fenofibrate and Metformin vs Metformin alone in subjects with Type 2 diabetes mellitus and dyslipidemia not appropriately controlled with a statin.

Principal Investigator: A multi-centric Phase 3 trial, durable trial randomised - For Type 2 DM - Comparison of premixed insulin Lispro low mixture and mid mix regimens with separate Bolus Insulin injections in patient with inadequate glycemic control on OHA who consume light breakfast.

Principal Investigator: Diabetic peripheral neuropathy - Neuropathic Pain: A cross-sectional survey of burden of illness.

Principal Investigator: A multi-centric Phase 3 trial randomised Phase 2/3, placebo-controlled, efficacy and safety study of once-weekly, subcutaneous LY2189265 compared to Sitagliptin in Patients with Type 2 Diabetes Mellitus on Metformin.

Principal Investigator: International Growth Database survey.

Principal Investigator: A randomised, open-label, parallel-group, multi-centre trial comparing the efficacy and safety of two devices one injection device to other transjection device of growth hormone in children with idiopathic growth hormone deficiency.

Principal Investigator: International Diabetes Management Practices Study.

[-]

Publications

Article

Extra hepatic portal venous obstruction in children: anthropometry, growth hormone and insulin-like growth factor-1. Mehrotra RN, Bahtia V, Dabadghao P, Yachha SK. Journal of Paediatric Gastroenterology and Nutrition. Nov 1997; 25 (5) 520-23.
Click here to read more.

Article

Beta cell function and insulin sensitivity in tropical calcific pancreatitis from North India. Mehrotra RN, Bhatia E, Chaudari G. Metabolism. Apr 1997; 46(4), 441-44.
Click here to read more.

Article

Growth charts suitable for evaluation of Indian children. Khadgwat, Dabadghao P, Mehrotra RN, Bhatia V. Indian Paediatrics. Sep 1998; 35(9) 859-65.
Click here to read more.

[+]

Article

Ectopic ACTH syndrome due to bronchial carcinoid tumour. A case report. Agarwal A, Mehrotra R, Mishra SK, Mithal A, Jain M, Gupta RK. Indian J Cancer. 1998; 35(2) 73-6.
Click here to read more.

Article

The clinical spectrum of fibro calculous diabetes in North India. Mittal N, Mehrotra R, Agarwal G, Rajeswari, Choudari G, Sikora S, Bhatia E. Natl Med J India. Nov-Dec 2002; 15(6): 327-31.
Click here to read more.

Article

Genetic analysis of SRD5A2 gene in Indian patients with 5 alpha reductase deficiency. Ravi Sahu, Raman Boddula, Pankaj Sharma, Vijayalakshmi Bhatia, Ronda Greaves, Sudha Rao, Meena Desai, Ashish Wakhlu, Shubha Phadke, Manoj Shukla, Preeti Dabadghao, Ravi N Mehrotra, Eesh Bhatia. (Accepted for publication).

Article

Lasafoxifene in post-menopausal women with osteoporosis. NEJM. 2010; Volume 362, Pg 686-696.

Article

Review article: Coronary heart disease in diabetes. Role of hyperglycemia and hyperinsulinemia. Mithal A, Mehrotra RN. International Journal of Diabetes in Developing Countries. 1995; Vol 15 (3).

Presentation

Childhood hyperparathyroidism with bilateral slipped femoral epiphysis, severe bone disease and vitamin D deficiency. In Paediatric Working Group. ASBMR, Sep 2007.

Presentation

Poster Presentation: Persistently elevated Parathormone after 12 months of parathyroid surgery. ASBMR, Sep 2011.

Presentation

Poster Presentation: International Diabetes Management Practices Study.

[-]

Training

MBBS: MLN Medical College, Allahabad. 1987.

MD (Med): MLN Medical College, Allahabad. 1991.

DM (Endocrinology): Sanjay Gandhi Post Graduate Institute of Medical Sciences (SGPGIMS), Lucknow. 1996.

[+]

DNB (Endocrinology): National Board of Examinations, New Delhi.

CCD: Certified Clinical Densitometrist. The International Society for Clinical Densitometry. 2002-17.

Lecture Delivered: Paget's Disease of Bone – Recent Advances. ESICON. Bangalore, Nov 2003.

Lecture Delivered: Introduction to Osteoporosis, DEXA and Bone Markers. Mid-Term Conference of Endocrine Society of India, Hyderabad. Jul-Aug 2004.

Lecture Delivered: Osteoporosis in Diabetes. DESERT, Bangalore. May 2005.

Lecture Delivered: Diabetes in Tuberculosis. DESERT, Bangalore. May 2006.

Faculty Member: Public Health Foundation of India (PHFI). Since 2010.

[-]

Dr. Rabindera Nath Mehrotra

Specialisation

Testimonials

Appointment Information

Research

Publications

Training

PERSONAL INFORMATION:

NON-PERSONAL INFORMATION: